View full meeting coverage »

Eyetube Meeting Coverage:




Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

OCS-01 in Phase 2: Topical Treatment for DME

  Channels: Retina | Posted 10/16/2020

Ramin Tadayoni, MD, PhD, explains the unique structure and formulation of OCS-01 (Oculis), a topical treatment for DME. Dr. Tadayoni also reviews the 150-patient phase 2 trial that evaluated changes in central macular thickness and BCVA in patients with DME who underwent therapy with OCS-01.

Clinical Trials • Diabetic macular edema, DME • macular thickness • retina-meeting-recap

3 / 6 Series: EURETINA 2020